tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Solvonis Therapeutics Streamlines Operations and Enhances R&D Focus
PremiumCompany AnnouncementsSolvonis Therapeutics Streamlines Operations and Enhances R&D Focus
4M ago
Solvonis Therapeutics Appoints Paul Carter as Non-Executive Director
Premium
Company Announcements
Solvonis Therapeutics Appoints Paul Carter as Non-Executive Director
4M ago
Solvonis Therapeutics Raises £1.25 Million to Boost CNS Disorder Programs
Premium
Company Announcements
Solvonis Therapeutics Raises £1.25 Million to Boost CNS Disorder Programs
4M ago
Solvonis Therapeutics Advances PTSD Programme with Promising Preclinical Results
PremiumCompany AnnouncementsSolvonis Therapeutics Advances PTSD Programme with Promising Preclinical Results
7M ago
Solvonis Therapeutics Advances SVN-002 Towards Phase 2b Trial for AUD
Premium
Company Announcements
Solvonis Therapeutics Advances SVN-002 Towards Phase 2b Trial for AUD
7M ago
Solvonis Therapeutics Raises Funds Through Warrant Exercise
Premium
Company Announcements
Solvonis Therapeutics Raises Funds Through Warrant Exercise
7M ago
Solvonis Therapeutics PLC Announces Change in Voting Rights Structure
PremiumCompany AnnouncementsSolvonis Therapeutics PLC Announces Change in Voting Rights Structure
8M ago
Solvonis Therapeutics Gains Research Coverage from Singer Capital Markets
Premium
Company Announcements
Solvonis Therapeutics Gains Research Coverage from Singer Capital Markets
8M ago
Solvonis Therapeutics Secures Key U.S. Patent for AI-Driven CNS Compounds
Premium
Company Announcements
Solvonis Therapeutics Secures Key U.S. Patent for AI-Driven CNS Compounds
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100